Shuwen Yu

A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells

Tao Zhang, Adel Hamza, Xianhua Cao et al. · Molecular Cancer Therapeutics · 2008 · 368 citations · Full text

Medicine, Oncology, Pharmacology +9

PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages

Lu Wang, Shuangshuang Li, Huanhua Luo et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 261 citations · Full text

Medicine, Cell Biology, Oncology +17

Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells

Mingliang Zhu, Pei-min Zhang, Min Jiang et al. · BMC Complementary Medicine and Therapies · 2020 · 87 citations · Full text

Life Sciences, Oncology, Pharmacology +17

ILT4 drives B7‐H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7‐H3 co‐expression correlates with poor prognosis in non‐small cell lung cancer

Pei Zhang, Shuwen Yu, Hongyu Li et al. · FEBS Letters · 2015 · 81 citations

Medicine, Immunology, Oncology +10

The Permeability of Puerarin Loaded Poly(butylcyanoacrylate) Nanoparticles Coated with Polysorbate 80 on the Blood–Brain Barrier and Its Protective Effect against Cerebral Ischemia/Reperfusion Injury

Li-Xia Zhao, Anchang Liu, Shuwen Yu et al. · Biological and Pharmaceutical Bulletin · 2013 · 58 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17